Financhill
Back

enVVeno Medical Quote, Financials, Valuation and Earnings

enVVeno Medical Price Quote

$3.49
-0.16 (-4.25%)
(Updated: November 12, 2024 at 5:55 PM ET)

enVVeno Medical Key Stats

Sell
35
enVVeno Medical (NVNO) is a Sell

Day range:
$3.53 - $3.68
52-week range:
$3.01 - $6.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
310.87
P/B ratio:
1.35%

Volume:
176K
Avg. volume:
120.7K
1-year change:
-19.54%
Market cap:
$63.9M
Revenue:
$0
EPS:
$-1.29

How Much Does enVVeno Medical Make?

Data Unavailable

Is enVVeno Medical Growing As A Company?

Data Unavailable

enVVeno Medical Stock Price Performance

  • Did enVVeno Medical Stock Go Up Last Month?
    enVVeno Medical share price went up by 13.2% last month
  • Did NVNO's Share Price Rise Over The Last Year?
    NVNO share price fell by -19.54% over the past 1 year

What Is enVVeno Medical 52-Week High & Low?

enVVeno Medical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy enVVeno Medical?

  • How Much Debt Does enVVeno Medical Have?
    Total long term debt quarterly is $0
  • How Much Cash Does enVVeno Medical Have?
    Cash and short term investments quarterly total is $48.4M
  • What Is enVVeno Medical’s Book Value Per Share?
    Book value per share is 2.70

Is enVVeno Medical Cash Flow Positive?

  • What Is NVNO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$16.7M
  • What Is enVVeno Medical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $39.4M
  • What Is enVVeno Medical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$9.8M

enVVeno Medical Return On Invested Capital

Data Unavailable

enVVeno Medical Earnings Date & Stock Price

enVVeno Medical Competitors

  • Who Are enVVeno Medical's Competitors?
    Below is a list of companies who compete with enVVeno Medical or are related in some way:
    • CVRx Inc (CVRX)
    • NeuroOne Medical Technologies Corp (NMTC)
    • Nutriband Inc (NTRB)
    • SINTX Technologies Inc (SINT)
    • Beyond Air Inc (XAIR)

enVVeno Medical Dividend Yield

enVVeno Medical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.06%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.00
Upside from Last Price: 393.83%

Major Shareholders

  • How many NVNO shares are owned by institutional investors?
    4.6M NVNO shares are owned by institutional investors
  • How many NVNO shares are owned by insiders?
    1.2M NVNO shares are owned by insiders